Acquired shares of ZOO LABO Inc. on December 29, 2025, making it a consolidated subsidiary. Acquisition funds were raised through an overseas public offering in July 2025.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2160","jir_company_name":"GNI Group Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-01-09","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/01\/2160-20260109-01.pdf","jir_short_summary":"Acquired shares of ZOO LABO Inc. on December 29, 2025, making it a consolidated subsidiary. Acquisition funds were raised through an overseas public offering in July 2025.","jir_summary":"### Overview of the M&A\nGNI Group Co., Ltd. has acquired shares of ZOO LABO Inc., a company engaged in the manufacturing of dental prosthetics and dental technology business utilizing CAD\/CAM, and has made it a consolidated subsidiary as of December 29, 2025. The acquisition funds were raised through an overseas public offering conducted in July 2025. ZOO LABO Inc. excels in providing high-quality dental prosthetics and promoting digitalization, aiming to create synergies with our MedTech business.\n\n### Outlook\nThe impact of this acquisition on the consolidated results for the fiscal year ending December 2025 will be minimal, with ZOO LABO Inc.'s performance reflected in consolidated results from the fiscal year ending December 2026 onwards. We believe this will contribute to mid- to long-term earnings improvement and plan to disclose additional information as necessary.","jir_financial_highlights":"Share Transfer Price: Unknown (Unknown)\nZOO LABO Inc. Revenue (Fiscal Year Ending December 2024): 1,723 million yen (Year-over-Year +9.1% (from 1,578 million yen in fiscal year ending December 2023))\nCapital (ZOO LABO Inc.): 85,750,000 yen (Unknown)","jir_category":"","jir_hashtags":"#GNIGroupCoLtd, #M&A, #JapaneseStocks","jir_key_figures":"Share Acquisition Date: December 29, 2025\nZOO LABO Revenue (Fiscal Year December 2024): 1,723 million yen\nCapital (ZOO LABO): 85,750,000 yen","jir_meta_title":"GNI Group Co., Ltd. Completes Acquisition of ZOO LABO Inc. as a Consolidated Subsidiary with Revenue of 1,723 Million Yen","jir_meta_description":"GNI Group Co., Ltd. completed the acquisition of shares of ZOO LABO Inc. as a consolidated subsidiary on December 29, 2025. Acquisition funds were procured through an overseas public offering in July 2025, aiming for mid- to long-term business expansion.","jir_og_title":"GNI Group Co., Ltd. Announces Completion of Consolidation of ZOO LABO Inc.","jir_og_description":"Completed acquisition of shares in dental technology company ZOO LABO Inc., strengthening the group\u2019s business foundation.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9370,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"m_and_a_alliance","footnotes":""},"sector":[],"importance":[],"class_list":["post-16570","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n